免费咨询热线:
产品中心
首页 > 产品中心 > 代理 > 代理品牌 > Matriks Biotek试剂盒代理

Matriks Biotek试剂盒代理

简要描述:Matriks Biotek试剂盒代理——北京百奥创新科技有限公司,提供Matriks Biotek elisa试剂盒等产品,更多Matriks Biotek品牌产品,欢迎选购!

  • 产品型号:型号齐全
  • 厂商性质:代理商
  • 更新时间:2024-11-04
  • 访  问  量:1345
详情介绍

一、Matriks Biotek公司介绍

Matriks Biotek公司成立于2002年,专门生产针对抗体药的ELISA试剂盒,用于检测抗体药的体内浓度或因使用抗体药而产生的抗体的体内浓度。Matriks Biotek产品达到ISO 13485 & CE IVD标准。目前,在30个国家有超过25个的大型制药企业都在使用其产品。   

抗体药(Monoclonal Antibody Drugs)是一类相对新型的生物制剂,是一类使用人工合成的单克隆抗体作为药物治疗的药物。抗体药这些抗体药物通过特异性地结合目标分子或细胞表面受体,发挥治疗作用。抗体药物具有高度的特异性和亲和力,可以选择性地结合目标分子或细胞表面受体,从而干扰或调节生物过程。因此,检测抗体药血药浓度及机体针对抗体药产生的抗体水平对指导治疗和个性化用药具有重要意义。目前,大量的临床和制药企业都在从事该项研究。   

抗体药物已被广泛应用于多种疾病的治疗,包括肿瘤、自身免疫性疾病、传染病等。它们可以作为单独的治疗药物使用,也可以与其他药物联合应用,以增强治疗效果。

二、Matriks Biotek试剂盒部分产品列表

货号

产品名称

MTB-COR-QNS-IGG-SRBD

CORONAHUNTER (Q-CORSRBD IgG) anti-Spike RBD IgG ELISA

MTB-COR-QNS-IGG-S1

CORONAHUNTER (Q-CORS1 IgG) anti-Spike 1 IgG ELISA

MTB-COR-QNS-IGG-NCP

CORONAHUNTER (Q-CORN IgG) anti-Nucleocapsid IgG   ELISA

MTB-COR-QNS-IGG-STRIM

CORONAHUNTER (Q-CORS IgG) anti-S Trimer IgG ELISA

MTB-COR-QNS-IGM-SRBD

CORONAHUNTER (Q-CORSRBD IgM) anti-Spike RBD IgM ELISA

MTB-COR-QNS-IGM-S1

CORONAHUNTER (Q-CORS1 IgM) anti-Spike 1 IgM ELISA

MTB-COR-QNS-IGM-NCP

CORONAHUNTER (Q-CORN IgM) anti-Nucleocapsid IgM   ELISA

MTB-COR-QNS-IGM-STRIM

CORONAHUNTER (Q-CORS IgM) anti-S Trimer IgM ELISA

MTB-COR-QNS-IGA-SRBD

CORONAHUNTER (Q-CORSRBD IgA) anti-Spike RBD IgA ELISA

MTB-COR-QNS-IGA-S1

CORONAHUNTER (Q-CORS1 IgA) anti-Spike 1 IgA ELISA

MTB-COR-QNS-IGA-NCP

CORONAHUNTER (Q-CORN IgA) anti-Nucleocapsid IgA ELISA

MTB-COR-QNS-IGA-STRIM

CORONAHUNTER (Q-CORS IgA) anti-S Trimer IgA ELISA

MTB-COR-QNS-IGE-SRBD

CORONAHUNTER (Q-CORSRBD IgE) anti-Spike RBD IgE ELISA

MTB-COR-QNS-IGE-S1

CORONAHUNTER (Q-CORS1 IgE) anti-Spike 1 IgE ELISA

MTB-COR-QNS-IGE-NCP

CORONAHUNTER (Q-CORN-SRBD IgE) anti-Nucleocapsid-S RBD IgE ELISA

MTB-COR-QNS-IGE-STRIM

CORONAHUNTER (Q-CORS IgE) anti-S Trimer IgE ELISA

MTB-INF-FD-REMI

Shikari (Q-INFLIXI) Infliximab (Remicade) ELISA

MTB-INF-SPEC-INF

Shikari (QS-INFLIXI) Infliximab (Remicade) ELISA

MTB-INF-QLS-REMI

Shikari (Q-ATI) Infliximab (Remicade) ELISA

MTB-INF-QNS-REMI

Shikari (Q-ATI) w/confirmation Infliximab (Remicade) ELISA

MTB-INF-QNFT-REMI

Shikari (Q-ATIDUO) Infliximab (Remicade) ELISA

MTB-INF-FD-REMS

Shikari (Q-REMS) Infliximab (Remsima) ELISA

MTB-INF-QLS-REMS

Shikari (S-AIR) Qualitative Infliximab (Remsima) ELISA

MTB-INF-QNS-REMS

Shikari (S-AIR) w/confirmation Infliximab (Remsima) ELISA

MTB-INF-QNFT-REMS

Shikari (S-AIR) Total semiquantitative Infliximab (Remsima) ELISA

MTB-ADA-FD-HUM

Shikari (Q-ADA) Adalimumab (Humira) ELISA

MTB-ADA-SPEC-ADA

Shikari (QS-ADA) Adalimumab (Humira) ELISA

MTB-ADA-QLS-HUM

Shikari (S-ATA)-Qualitative Adalimumab (Humira) ELISA

MTB-ADA-QNS-HUM

Shikari (S-ATA) w/confirmation Adalimumab (Humira) ELISA

MTB-ADA-QNFT-HUM

Shikari (S-ATA)-Free/Total semiquantitative Adalimumab (Humira) ELISA

MTB-ETA-FD-ENB

Shikari (Q-ETA) Etanercept (Enbrel) ELISA

MTB-ETA-QLS-ENB

Shikari (S-ATE) Etanercept (Enbrel) ELISA

MTB-GOL-FD-SIM

Shikari (Q-GOL) Golimumab (Simponi) ELISA

MTB-GOL-QLS-SIM

Shikari (S-ATG) Golimumab (Simponi) ELISA

MTB-GOL-QNS-SIM

Shikari (S-ATG) w/confirmation Golimumab (Simponi) ELISA

MTB-CER-FD-CIM

Shikari (Q-CERT) Certolizumab (Cimzia) ELISA

MTB-CER-QNS-CIM

Shikari (S-ATCER) Certolizumab (Cimzia) ELISA

MTB-VED-SPEC-VED

Shikari (QS-VEDO) Vedolizumab (Entyvio) ELISA

MTB-VED-FD-ENT

Shikari (Q-VEDO) Vedolizumab (Entyvio) ELISA

MTB-VED-QLS-ENT

Shikari (S-ATV) Vedolizumab (Entyvio) ELISA

MTB-VED-QNS-ENT

Shikari (S-ATV) w/confirmation Vedolizumab (Entyvio) ELISA

MTB-UST-FD-STE

Shikari (Q-UST) Ustekinumab (Stelara) ELISA

MTB-UST-SPEC-STE

Shikari (QS-UST) Ustekinumab (Stelara) ELISA

MTB-UST-QLS-STE

Shikari (S-ATU) Ustekinumab (Stelara) ELISA

MTB-UST-QNS-STE

Shikari (S-ATU) w/confirmation Ustekinumab (Stelara) ELISA

MTB-RAM-FD-CYR

Shikari (Q-RAM) Ramucirumab (Cyramza) ELISA

MTB-RAM-QLS-CYR

Shikari (S-ATRAM) Ramucirumab (Cyramza) ELISA

MTB-BEV-FD-AA

Shikari (Q-BEVA) Bevacizumab (Avastin) ELISA

MTB-BEV-QLS-AA

Shikari (S-ATB) Bevacizumab (Avastin) ELISA

MTB-BEV-QNS-AA

Shikari (S-ATB) w/confirmation Bevacizumab (Avastin) ELISA

MTB-RIT-FD-RM

Shikari (Q-RITUX) Rituximab (Rituxan, Mabthera) ELISA

MTB-RIT-QLS-RM

Shikari (S-ATR) Rituximab (Rituxan, Mabthera) ELISA

MTB-RIT-QNS-RM

Shikari (S-ATR) w/confirmation Rituximab (Rituxan, Mabthera) ELISA

MTB-TRA-FD-HH

Shikari (Q-TRAS) Trastuzumab (Herceptin, Herclon) ELISA

MTB-TRA-QLS-HH

Shikari (S-ATT) Trastuzumab (Herceptin, Herclon) ELISA

MTB-TRA-QNS-HH

Shikari (S-ATT) w/confirmation Trastuzumab (Herceptin, Herclon) ELISA

MTB-CET-FD-ERB

Shikari (Q-CET) Cetuximab (Erbitux) ELISA

MTB-CET-QLS-ERB

Shikari (S-ATC) Cetuximab (Erbitux) ELISA

MTB-CET-QNS-ERB

Shikari (S-ATC) w/confirmation Cetuximab (Erbitux) ELISA

MTB-DEN-FD-PRO

Shikari (Q-DEN) Denosumab (Prolia) ELISA

MTB-DEN-QLS-PRO

Shikari (S-ATD) Denosumab (Prolia) ELISA

MTB-DEN-QNS-PRO

Shikari   (S-ATD) w/confirmation Denosumab (Prolia) ELISA

MTB-FIL-QNS-FRA

Shikari (Q-AFA) Filgrastim ELISA

MTB-OMA-FD-XOL

Shikari (Q-OMA) Omalizumab (Xolair) ELISA

MTB-OMA-QLS-XOL

Shikari (S-ATO) Omalizumab (Xolair) ELISA

MTB-RAN-FD-LUC

Shikari (Q-RAN) Ranibizumab (Lucentis) ELISA

MTB-AVE-FD-BAV

Shikari (Q-AVE) Avelumab (Bavencio) ELISA

MTB-AVE-QLS-BAV

Shikari (S-ATAV) Avelumab (Bavencio) ELISA

MTB-NIV-FD-OPD

Shikari (Q-NIVO) Nivolumab (Opdivo) ELISA

MTB-NIV-QLS-OPD

Shikari (S-ATN) Nivolumab (Opdivo) ELISA

MTB-NIV-QNS-OPD

Shikari (S-ATN) w/confirmation Nivolumab (Opdivo) ELISA

MTB-PEM-FD-KEY

Shikari (Q-PEM) Pembrolizumab (Keytruda) ELISA

MTB-PEM-QLS-KEY

Shikari (S-ATP) Pembrolizumab (Keytruda) ELISA

MTB-PEM-QNS-KEY

Shikari (S-ATP) w/confirmation Pembrolizumab (Keytruda) ELISA

MTB-IPI-FD-YER

Shikari (Q-IPI) Ipilimumab (Yervoy) ELISA

MTB-IPI-QLS-YER

Shikari (S-ATI) Ipilimumab (Yervoy) ELISA

MTB-IPI-QNS-YER

Shikari (S-ATI) w/confirmation Ipilimumab (Yervoy) ELISA

MTB-TOC-FD-ACT

Shikari (Q-TOC) Tocilizumab (Actemra) ELISA

MTB-TOC-QLS-ACT

Shikari (S-ATOC) Tocilizumab (Actemra) ELISA

MTB-TOC-QNS-ACT

Shikari (S-ATOC) w/confirmation Tocilizumab (Actemra) ELISA

MTB-NAT-FD-TYS

Shikari (Q-NAT) Natalizumab (Tysabri) ELISA

MTB-NAT-QLS-TYS

Shikari (S-ATNAT) Natalizumab (Tysabri) ELISA

MTB-NAT-QNS-TYS

Shikari (S-ATNAT) w/confirmation Natalizumab (Tysabri) ELISA

MTB-AFL-FD-EYL

Shikari (Q-AF) Aflibercept (Eylea) ELISA

MTB-AFL-FD-SENS-EYL

Shikari (Q-AF) High Sensitive Aflibercept (Eylea) ELISA

MTB-AFL-QLS-EYL

Shikari (S-ATAF) Aflibercept (Eylea) ELISA

MTB-AFL-QNS-EYL

Shikari (S-ATAF) w/confirmation Aflibercept (Eylea) ELISA

MTB-CAN-FD-ILA

Shikari (Q-CAN) Canakinumab (Ilaris) ELISA

MTB-CAN-QLS-ILA

Shikari (S-ATCAN) Canakinumab (Ilaris) ELISA

MTB-CAN-QNS-ILA

Shikari (S-ATCAN) w/confirmation Canakinumab (Ilaris) ELISA

MTB-DUR-FD-IMF

Shikari (Q-DUR) Durvalumab (Imfinzi) ELISA

MTB-DUR-QLS-IMF

Shikari (S-ATDUR) Durvalumab (Imfinzi) ELISA

MTB-ATE-FD-TEC

Shikari (Q-ATE) Atezolizumab (Tecentriq) ELISA

MTB-ATE-QLS-TEC

Shikari (S-ATAT) Atezolizumab (Tecentriq) ELISA

MTB-DAR-FD-DAR

Shikari (Q-DAR) Daratumumab (Darzalex) ELISA

MTB-DAR-QLS-DAR

Shikari (S-ATDAR) Daratumumab (Darzalex) ELISA

MTB-ABA-FD-ORE

Shikari (Q-ABA) Abatacept (Orencia) ELISA

MTB-ABA-QLS-ORE

Shikari (S-ATAB) Abatacept (Orencia) ELISA

MTB-ABA-QNS-ORE

Shikari (S-ATAB) w/confirmation Abatacept (Orencia) ELISA

MTB-SEC-FD-VER

Shikari (Q-SEC) Secukinumab (Cosentyx , Verxant) ELISA

MTB-SEC-QLS-VER

Shikari (S-ATSEC) Secukinumab (Cosentyx , Verxant) ELISA

MTB-EVO-FD-REP

Shikari (Q-EVO) Evolocumab (Repatha ) ELISA

MTB-EVO-QLS-REP

Shikari (S-ATEVO) Evolocumab (Repatha ) ELISA

MTB-PAL-FD-SYN

Shikari (Q-PAL) Palivizumab (Synagis ) ELISA

MTB-PAL-QLS-SYN

Shikari (S-ATPAL) Palivizumab (Synagis ) ELISA

MTB-PAL-QNS-SYN

Shikari (S-ATPAL) w/confirmation Palivizumab (Synagis ) ELISA

MTB-IXE-FD-TAL

Shikari (Q-IXE) Ixekizumab (Taltz ) ELISA

MTB-IXE-QLS-TAL

Shikari (S-ATIXE) Ixekizumab (Taltz ) ELISA

MTB-PER-FD-PER

Shikari (Q-PER) Pertuzumab (Perjeta ) ELISA

MTB-PER-QLS-PER

Shikari (S-ATPER) Pertuzumab (Perjeta ) ELISA

MTB-RIS-FD-SKY

Shikari (Q-RIS) Risankizumab (Skyrizi ) ELISA

MTB-RIS-QLS-SKY

Shikari (S-ATRIS) Risankizumab (Skyrizi ) ELISA

MTB-RIS-QNS-SKY

Shikari (S-ATRIS) w/confirmation Risankizumab (Skyrizi ) ELISA

MTB-ECU-FD-SOL

Shikari (Q-ECU) Eculizumab (Soliris ) ELISA

MTB-ECU-QLS-SOL

Shikari (S-ATEC) Eculizumab (Soliris ) ELISA

MTB-ECU-QNS-SOL

Shikari (S-ATEC) w/confirmation Eculizumab (Soliris ) ELISA

三、Matriks Biotek试剂盒代理简介

Matriks Biotek试剂盒代理——北京百奥创新科技有限公司,2017年在北京成立。依托中科院的科研技术力量,整合经验丰富的商业团队及管理团队组建而成,专注于免疫学、细胞生物学、分子生物学等领域核心试剂产品的研发、生产与销售。百奥创新在产品自主研发的同时,也与*多家生命科学试剂供应商建立良好的合作关系,基于“客户第一"的核心理念,向全国10000+客户提供200000+优质产品。公司以北京运营中心为主体,在天津、上海、浙江、江苏、广州、深圳、武汉、成都、重庆等地建立办事处及联络中心,并建有北京、天津、深圳三大专业化库存与物流基地,以更好地服务全国客户。

百奥创新将以品质树立品牌,以服务赢得口碑,致力于成长为重要的生物原料及生物化学试剂开发与成果转化的开tuo者,并成为行业TOP供应商。

 

Matriks Biotek试剂盒代理


留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7